Johnson & Johnson

Johnson & Johnson, a leading pharmaceutical, medical device, and consumer packaged products manufacturer was established in 1886 in New Brunswick, New Jersey. With a total sales figure of 94.9 billion USD in 2022, it holds a significant position in the global market. The corporation operates across three main segments: medical devices and diagnostics, pharmaceuticals, and consumer packaged goods. Notably, the consumer packaged goods segment contributed 15 billion USD to the company's global revenue in 2022.

Johnson & Johnson's pharmaceutical business has experienced substantial growth in recent years, representing approximately 55 percent of its total sales. The company focuses on key therapeutic areas, including immunology, oncology, infectious diseases, and vaccinations. In February 2021, Johnson & Johnson sought emergency use permission from the FDA (U.S. Food and Drug Administration) for its COVID-19 vaccine, generating significant interest due to its single-shot administration and non-demanding storage requirements.

As of 2022, Johnson & Johnson retains its position as the world's most valuable biotech and pharmaceutical company in terms of market value. Diversified as a healthcare corporation, it owns renowned brands such as Band-Aid, Neutrogena, Tylenol, and Acuvue contact lenses through its extensive network of over 250 subsidiaries. Over the past two decades, the company has consistently increased its workforce, reaching a record high of approximately 153,000 employees by the end of 2022.

Founded: 1886
Headquarters: Johnson and Johnson Plaza, New Brunswick, New Jersey, U.S.
Website: https://www.jnj.com/